Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hegele

Showing results (1-10 of 1,071) with videos related to

Pageof 108
Sort By:
Der Urologe. Ausg. A|March 24, 2016
[Renal and ureteral injuries. Diagnosis and treatment]A Hegele
Clinical Chemistry|September 3, 1999
Uncovering rare mutations: an unforeseen complication of routine genotyping of APOER A Hegele
Circulation|May 23, 2001
Premature atherosclerosis associated with monogenic insulin resistanceR A Hegele
Stroke|January 21, 2003
Genetic association studies of stroke: hope, signal, and noiseRobert A Hegele
The Canadian Journal of Cardiology|December 1, 1992
Lipoprotein(a) and fibrinolysisR A Hegele
The Lancet. Diabetes & Endocrinology|April 25, 2017
Insulin affordabilityRobert A Hegele
Current Atherosclerosis Reports|December 21, 2000
Angiotensin-converting enzyme (ACE) inhibition in the secondary prevention of vascular disease: the Heart Outcomes Prevention Evaluation (HOPE) Trial and its substudiesR A Hegele
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2010
Genome-wide association studies of plasma lipids: have we reached the limit?Robert A Hegele
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|June 1, 1996
The role of lipids in cardiovascular disease: lessons from rare mutations and special populationsR A Hegele
The Canadian Journal of Cardiology|November 1, 1992
Lipoprotein(a): biochemistry and geneticsR A Hegele
Pageof 108

Showing results (1-10 of 1,071) with videos related to

Sort By:
Pageof 108
Der Urologe. Ausg. A|March 24, 2016
[Renal and ureteral injuries. Diagnosis and treatment]A Hegele
Clinical Chemistry|September 3, 1999
Uncovering rare mutations: an unforeseen complication of routine genotyping of APOER A Hegele
Circulation|May 23, 2001
Premature atherosclerosis associated with monogenic insulin resistanceR A Hegele
Stroke|January 21, 2003
Genetic association studies of stroke: hope, signal, and noiseRobert A Hegele
The Canadian Journal of Cardiology|December 1, 1992
Lipoprotein(a) and fibrinolysisR A Hegele
The Lancet. Diabetes & Endocrinology|April 25, 2017
Insulin affordabilityRobert A Hegele
Current Atherosclerosis Reports|December 21, 2000
Angiotensin-converting enzyme (ACE) inhibition in the secondary prevention of vascular disease: the Heart Outcomes Prevention Evaluation (HOPE) Trial and its substudiesR A Hegele
Arteriosclerosis, Thrombosis, and Vascular Biology|October 22, 2010
Genome-wide association studies of plasma lipids: have we reached the limit?Robert A Hegele
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|June 1, 1996
The role of lipids in cardiovascular disease: lessons from rare mutations and special populationsR A Hegele
The Canadian Journal of Cardiology|November 1, 1992
Lipoprotein(a): biochemistry and geneticsR A Hegele
Pageof 108